{
    "2021-01-15": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Novartis' Ligelizumab Gets Breakthrough Therapy Status",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Ligelizumab",
                        "Breakthrough",
                        "Therapy",
                        "Status"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "LLY",
                        "Alzheimer",
                        "Disease",
                        "Data",
                        "NVS",
                        "SNY",
                        "M&A",
                        "Deals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}